What is Monogram Health?
Headquartered in Nashville, Tennessee, Monogram Health operates as a specialized benefit management and care delivery organization. By integrating next-generation artificial intelligence with evidence-based clinical criteria, the firm provides a comprehensive suite of services, including complex case management, utilization management, and medication therapy management. Its model is designed to optimize health outcomes by delaying disease progression and facilitating seamless transitions to dialysis or pre-emptive kidney transplants.
The company distinguishes itself through a collaborative ecosystem, partnering with health plans, physician practices, and clinically integrated health systems. By deploying a national network of nephrologists and providing individualized at-home care, Monogram Health effectively bridges the gap between traditional clinical settings and patient-centric, home-based nephrology services.
How much funding has Monogram Health raised?
Monogram Health has raised a total of $542M across 3 funding rounds:
Series A
$7M
Series B
$160M
Other Financing Round
$375M
Series A (2020): $7M, investors not publicly disclosed
Series B (2021): $160M led by Norwest Venture Partners, TPG, Frist Cressey Ventures, and Humana
Other Financing Round (2023): $375M supported by Memorial Hermann, TPG, Humana, Cigna Ventures, SCAN Health Plan, and CVS Health
Key Investors in Monogram Health
Memorial Hermann
Memorial Hermann Health System is a prominent not-for-profit healthcare organization based in Houston, providing a comprehensive range of clinical services, specialty care, and rehabilitation facilities.
TPG
TPG is a global alternative asset management firm that manages capital across private equity, growth equity, and impact investing, focusing on long-term value creation in diverse industries.
Humana
Humana is a leading health insurance provider committed to personalized care and community-level health improvements, offering solutions that help members achieve better health outcomes.
What's next for Monogram Health?
With the recent influx of $375M, Monogram Health is well-positioned to accelerate its strategic roadmap. The focus is expected to remain on deepening its penetration within the U.S. healthcare market and refining its AI-driven care planning tools. As the company continues to scale, the emphasis will likely shift toward strengthening its partnerships with major health systems and expanding its reach to underserved populations, thereby reinforcing its role as a critical infrastructure provider in the renal care landscape. The backing from institutional heavyweights suggests a long-term commitment to systemic healthcare transformation and the continued professionalization of home-based chronic disease management.
See full Monogram Health company page
